Unknown

Dataset Information

0

Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus.


ABSTRACT: Respiratory syncytial virus (RSV) is the leading cause of hospitalization for children under 5 years of age. We sought to engineer a viral antigen that provides greater protection than currently available vaccines and focused on antigenic site Ø, a metastable site specific to the prefusion state of the RSV fusion (F) glycoprotein, as this site is targeted by extremely potent RSV-neutralizing antibodies. Structure-based design yielded stabilized versions of RSV F that maintained antigenic site Ø when exposed to extremes of pH, osmolality, and temperature. Six RSV F crystal structures provided atomic-level data on how introduced cysteine residues and filled hydrophobic cavities improved stability. Immunization with site Ø-stabilized variants of RSV F in mice and macaques elicited levels of RSV-specific neutralizing activity many times the protective threshold.

SUBMITTER: McLellan JS 

PROVIDER: S-EPMC4461862 | biostudies-literature | 2013 Nov

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4963090 | biostudies-literature
| S-EPMC5072732 | biostudies-literature
| S-EPMC4476739 | biostudies-literature
| S-EPMC5658087 | biostudies-literature
| S-EPMC6275507 | biostudies-literature
| S-EPMC3147929 | biostudies-literature
| S-EPMC6922093 | biostudies-literature
2024-03-05 | PXD048897 | Pride
| S-EPMC5372572 | biostudies-other
| S-EPMC9006937 | biostudies-literature